These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35940315)

  • 21. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.
    Pang PS; Kamal A; Glenn JS
    Liver Transpl; 2009 Sep; 15(9):1126-32. PubMed ID: 19718638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.
    Woolley AE; Piechura LM; Goldberg HJ; Singh SK; Coppolino A; Baden LR; Mallidi HR
    Ann Cardiothorac Surg; 2020 Jan; 9(1):42-48. PubMed ID: 32175238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
    Kucirka LM; Peters TG; Segev DL
    Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor Risk Index for African American liver transplant recipients with hepatitis C virus.
    Shores NJ; Dodge JL; Feng S; Terrault NA
    Hepatology; 2013 Oct; 58(4):1263-9. PubMed ID: 23696235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Cannon RM; Locke JE; Orandi BJ; Anderson DJ; Davis EG; Mackelaite L; Dave H; Eng M; Jones CM
    Transplantation; 2020 Jun; 104(6):1215-1228. PubMed ID: 31517783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database.
    Dhillon GS; Levitt J; Mallidi H; Valentine VG; Gupta MR; Sista R; Weill D
    Transplantation; 2009 Sep; 88(6):842-6. PubMed ID: 19920785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation.
    Ali MK; Light JA; Barhyte DY; Sasaki TM; Currier CB; Grandas O; Fowlkes D
    Transplantation; 1998 Dec; 66(12):1694-7. PubMed ID: 9884261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient.
    Khan B; Singer LG; Lilly LB; Chaparro C; Martinu T; Juvet S; Pipkin M; Waddell TK; Keshavjee S; Humar A; Cypel M
    Am J Transplant; 2017 Apr; 17(4):1129-1131. PubMed ID: 27873483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of diabetes and acute rejection on liver transplant outcomes: An analysis of the organ procurement and transplantation network/united network for organ sharing database.
    Kuo HT; Lum E; Martin P; Bunnapradist S
    Liver Transpl; 2016 Jun; 22(6):796-804. PubMed ID: 26850091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Center-level Utilization of Hepatitis C Virus-positive Donors for Orthotopic Heart Transplantation.
    Huckaby LV; Seese LM; Handzel R; Wang Y; Hickey G; Kilic A
    Transplantation; 2021 Dec; 105(12):2639-2645. PubMed ID: 33988340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of lung transplantation at a Canadian center using donors declined in the United States.
    Cypel M; Yeung J; Donahoe L; Yasufuku K; Wang A; Pietroski R; Lange P; Pierre A; De Perrot M; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1661-1668.e1. PubMed ID: 35461711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
    Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
    Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Lung Transplantation From Hepatitis C Viremic Donors.
    Li SS; Osho A; Moonsamy P; Wolfe S; Villavicencio MA; Langer N; Sundt TM; Funamoto M
    Ann Thorac Surg; 2022 May; 113(5):1598-1607. PubMed ID: 34062125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.